Combination of Hypofractionated Radiation Therapy and Gilvetmab for the Treatment of Cutaneous or Subcutaneous Mast Cell Tumours in Dogs.

Martin TW, Thamm DH, Weishaar KM

Open source

DOI
10.1111/vco.70110
Published
2026 Sep 1
Container
Veterinary and comparative oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/vco.70110,
  title = {Combination of Hypofractionated Radiation Therapy and Gilvetmab for the Treatment of Cutaneous or Subcutaneous Mast Cell Tumours in Dogs.},
  author = {Martin TW and Thamm DH and Weishaar KM},
  year = {2026},
  journal = {Veterinary and comparative oncology},
  doi = {10.1111/vco.70110},
  url = {https://doi.org/10.1111/vco.70110}
}

RIS

TY  - JOUR
TI  - Combination of Hypofractionated Radiation Therapy and Gilvetmab for the Treatment of Cutaneous or Subcutaneous Mast Cell Tumours in Dogs.
AU  - Martin TW
AU  - Thamm DH
AU  - Weishaar KM
PY  - 2026
JO  - Veterinary and comparative oncology
DO  - 10.1111/vco.70110
UR  - https://doi.org/10.1111/vco.70110
ER  - 

APA

TW, M., DH, T., & KM, W. (2026). Combination of Hypofractionated Radiation Therapy and Gilvetmab for the Treatment of Cutaneous or Subcutaneous Mast Cell Tumours in Dogs.. Veterinary and comparative oncology. https://doi.org/10.1111/vco.70110

Source records